Vaccines news
|
view more news
30-Apr-2009
Novartis investigational adjuvanted (MF59) pre-pandemic avian influenza vaccine Aflunov® shows long lasting, broadly crossprotective immune response
(106 KB)
28-Apr-2009
Dr. Rino Rappuoli, Head of Research for Novartis Vaccines, Honored with Prestigious Albert B. Sabin Gold Medal for Reverse Vaccinology
(59 KB)
Features
April 25
Novartis in the fight against malaria
World Malaria Day, an opportunity to reflect on the progress made in finding sustainable solutions for malaria. more ›
About Novartis Vaccines
Novartis Vaccines is the world's fifth-largest vaccines business.
Careers
Our success depends on the creativity and performance of our associates.
Swine Flu
Novartis is working with health authorities around the world.
